Tag: Pharmaceutical | Page 75 | NAI 500 | Page 75

- English
  - 简体中文
  - 繁體中文

Home
Pharmaceutical

Filter

Beijing Surgerii Completes A Round for Next-Gen Robotic Surgery Device

Feb 27, 2019

Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics

Feb 26, 2019

CStone Pharma Completes $285 Million Hong Kong IPO; Trades Higher

Feb 26, 2019

Shanghai Henlius’ Rituxan Biosimilar is First Biosimilar Approved in China

Feb 26, 2019

Xynomic Starts Phase III Trial of HDAC Inhibitor in South Korea

Feb 25, 2019

Gracell Biotech of Suzhou Completes $85 Million Series B for Immune Cell Gene Therapies

Feb 25, 2019

Novartis gene therapy would be cost effective up to $900,000 -U.S. group，诺华基因疗法Zolgensma的成本效益惊人

Novartis gene therapy would be cost effective up to $900,000 -U.S. group

Feb 22, 2019

PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU

Feb 22, 2019

Solasia Announces China Approvals for Two Cancer Side-Effect Treatments

Feb 22, 2019

BiomX nets $32M to engineer bacteria-killing viruses for IBD and acne

Feb 21, 2019

WuXi STA Pharma Forms Drug Delivery Collaboration with BioLingus

Feb 21, 2019

Happy Life and PPD to Offer China Clinical Trial/Post-Marketing Services

Feb 21, 2019

Owlstone to Test Breath Biopsy Diagnostic at Shanghai Renji Hospital

Feb 20, 2019

Shukun Raises $29.5 Million for AI-based Hospital Diagnosis in China

Feb 20, 2019

HuaSin In-licenses China Rights to HPV Diagnostic from Spain’s Genomica

Feb 20, 2019

Beijing GenomePrecision Raises $15 Million for Molecular Diagnostics

Feb 20, 2019

NMPA Allows Diabetes Treatment Synjardy’s Marketing in China

Feb 20, 2019

Novo Nordisk Snags FDA Approval for Hemophilia A Treatment

Feb 19, 2019